Recommendations for the Evaluation and Treatment of Neonatal Autoimmune and Alloimmune Thrombocytopenia

J Bussel; C Kaplan; J McFarland; Working Party on Neonatal Immune Thrombocytopenia of the Neonatal Hemostasis Subcommittee of the Scientific and Standardization Committee of the ISTH

doi:10.1055/s-0038-1648202

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1991; 65(05): 631-634
DOI: 10.1055/s-0038-1648202

Scientific and Standardization Committee Communications

Schattauer GmbH Stuttgart

Recommendations for the Evaluation and Treatment of Neonatal Autoimmune and Alloimmune Thrombocytopenia

J Bussel

The Department of Pediatrics, Cornell Medical College, New York, N.Y., U.S.A., the Institut National de Transfusion Sanguine, Paris, France, and Blood Center of Southeast Wisconsin, U.S.A.

,

C Kaplan

The Department of Pediatrics, Cornell Medical College, New York, N.Y., U.S.A., the Institut National de Transfusion Sanguine, Paris, France, and Blood Center of Southeast Wisconsin, U.S.A.

,

J McFarland

The Department of Pediatrics, Cornell Medical College, New York, N.Y., U.S.A., the Institut National de Transfusion Sanguine, Paris, France, and Blood Center of Southeast Wisconsin, U.S.A.

,

Working Party on Neonatal Immune Thrombocytopenia of the Neonatal Hemostasis Subcommittee of the Scientific and Standardization Committee of the ISTH

› Author Affiliations

Abstract

PDF Download

Summary

The following recommendations of the Neonatal Hemostasis Subcommittee of the Scientific and Standardization Committee of the ISTH for the management of neonatal immune thrombocytopenia were prepared by the working party on neonatal immune thrombocytopenia. Evaluation, diagnosis, and treatment of the mother and neonate with alloimmune and autoimmune thrombocytopenia are discussed and current recommendations provided. This document is likely to require frequent future revision(s).

PDF (960 kb)

References

References
1 Hart D, Dunetz C, Nardi M, Porges R, Weiss A, Karpatkin M. An epidemic of maternal thrombocytopenia associated with elevated antiplatelet antibody. Am J Obstet Gynecol 1986; 154: 878-883
2 Burrows R, Kelton J. Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med 1988; 319: 142-145
3 Burrows R, Kelton J. Thrombocytopenia at delivery: A prospective survey of 6715 deliveries. Am J Obstet Gynecol 1990; 162: 731-734
4 Samuels P, Bussel J, Braitman L, Tomaski A, Druzin M, Mennuti M, Cines D. Estimation of the risk of thrombocytopenia in the offspring of pregnant woman with presumed ITP. N Engl J Med 1990; 323: 229-235
5 Kaplan C, Daffos F, Forestier F, Tertian G, Catherine N, Pons J, Tchemia F. Fetal platelet counts in thrombocytopenic pregnancy. Lancet (in press)
6 Burrows R, Kelton J. Idiopathic thrombocytopenia purpura during pregnancy: Intervention for the fetus is not required. Am J Obstet Gynecol (in press)
7 Ballern P, Buskard N, Wittmann B, Wilson R, Effer S, Farquaharson D. ITP in pregnancy: Use of the bleeding time as an indicator for treatment. Blut 1989; 59: 132-135
8 Cines D, Dusak B, Tomaski A, Mennuti M, Schreiber A. Immune thrombocytopenic purpura and pregnancy. N Engl J Med 1982; 306: 826-831
9 Ayromlooi J. A new approach to the management of immunologic thrombocytopenic purpura in pregnancy. Am J Obstet Gynecol 1978; 130: 235-236
10 Scioscia A, Grannum P, Copel J, Hobbins J. The use of percutaneous umbilical blood sampling in immune thrombocytopenic purpura. Am J Obstet Gynecol 1988; 159: 1066-1068
11 Christiaens G, Helmerhorst F. Validity of intrapartum diagnosis of fetal thrombocytopenia. Am J Obstet Gynecol 1987; 157: 864-865
12 Pielet B, Socol M, MacGregor S, Ney J, Dooley S. Cordocentesis: An appraisal of risks. Am J Obstet Gynecol 1988; 159: 1497-1500
13 Daffos F. Technical aspects of prenatal samplings and fetal transfusion. Curr Stud Hematol Blood Transfus 1988; 55: 127-129
14 Karpatkin M, Porges R, Karpatkin S. Platelet counts in infants of women with autoimmune thrombocytopenia. Effects of steroid administration to mother. N Engl J Med 1981; 305: 936-939
15 Christiaens G. Controlled trial of antenatal steroid administration to mothers with ITP. Br J Obstet Gynecol (in press)
16 Nathan D, Oski F. Hematology of Infancy and Childhood. Third Edition. W. B. Saunders Company; Philadelphia: 1987
17 Ballin A, Andrew M, Ling E, Perlman M, Blanchette V. High dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. J Pediatr 1988; 112: 789-792
18 Bridges J, Carre IJ. Congenital thrombocytopenic purpura treated by exchange transfusion. Arch Dis Child 1961; 36: 210-213
19 Bauman M, Menitove J, Aster R, Anderson T. Urgent treatment of idiopathic thrombocytopenia purpura with single-dose gammaglobulin infusion followed by platelet transfusion. Ann Intern Med 1986; 104: 808
20 Blanchette V, Chen L, DeFriedberg A, Hogan V, Trudel E, Decary F. Alloimmunization to the PLA1 platelet antigen: results of a prospective study. Br J Hematol 1990; 74: 209-215
21 Mueller-Eckhardt C, Mueller-Eckhardt G, Willen-Ohff H, Horz A, Kuenzlen E, O’Neill G, Schendel D. Immunogenicity: Immunogenic-ity of and immune response to the human platelet antigen Zwa is strongly associated with HLA-B8 and DR3. Tissue Antigens 1985; 26: 71-76
22 Kaplan C, Daffos F, Forestier F, Cox W, Lyon-Caen E, Dupuy-Montbrun M. Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets. Blood 1988; 72: 340-345
23 Mueller-Eckhardt C, Mueller-Eckhardt G, Grubert A, Weisheit M, Kief el V, Kroll H, Schmidt S, Santoso S. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989; 2: 363-366
24 Schulman N, Jordan JV. Platelet immunology. In: Hemostasis and Thrombosis 1988 Coleman RW, Hirsh J, Marder VJ, Salzman FW. (eds)
25 Shibata Y, Miyaji T, Ichikawa Y, Matsuda I. A new platelet system, yuka/yukb. Vox Sang 1986; 51: 334-336
26 Friedman J, Aster R. Neonatal alloimmune thrombocytopenic purpura and congenital porencephaly in two siblings associated with a “new” maternal antiplatelet antibody. Blood 1985; 65: 1412-1415
27 Bussel J, Berkowitz R, McFarland J, Lynch L, Chitkara U. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Engl J Med 1988; 319: 1374-1378
28 Forestier F. Biological characterization of prenatal samplings. Curr Stud Hematol Blood Transfus 1988; 55: 130-141
29 Lynch L, Bussel J, Goldberg J, Chitkara U, Wilkins I, MacFarland J, Berkowitz R. The in utero diagnosis and management of alloimmune thrombocytopenia. Prenat Diagn 1988; 8: 329-333
30 Kaplan C, Patereau C, Reznikoff-Etievant M, Muller J, Dumez Y, Kesseler A. Antenatal PLA typing and detection of GP IIb-IIIa complex. Br J Haematol 1985; 60: 586-588
31 Gruel Y, Boizard B, Daffos F, Forestier F, Caen J, Wautier J. Determination of platelet antigens and glycoprotein in the human fetus. Blood 1986; 68: 488-492
32 Newman P, Derbes R, Aster R. The human platelet alloantigens PLA1 and PLA2, are associated with a leucine 33/proline 33 amino acid polymorphism in membrane glycoprotein IIIa and are distinguishable by DNA typing. J Clin Invest 1989; 83: 778
33 Herman J, Jumbelic M, Ancona R, Kickler T. In utero cerebral hemorrhage in alloimmune thrombocytopenia. Am J Ped Hematol Oncol 1986; 8: 32-37
34 Bussel J. Neonatal alloimmune thrombocytopenia (NAIT): information derived from a prospective international registry. Blood 1987 70. 6a (abstract)
35 Bussel J, McFarland J, Berkowitz R. Antenatal management of fetal alloimmune and autoimmune thrombocytopenia. Transfus Med Rev 1990; 2: 49-62
36 Daffos F, Forestier F, Kaplan C. Prenatal treatment of fetal alloimmune thrombocytopenia. Lancet 1988; 2: 90 c
37 Nicolini U, Rodeck CH, Kochenour NK. et al In-Utero platelet transfusion for alloimmune thrombocytopenia. Lancet 1988; 2: 506
38 Daffos F, Forestier F, Muller JY. et al Prenatal treatment of alloimmune thrombocytopenia. Lancet 1984; 2: 632